TEL is an anti-fibrotic agent that can inhibit cancer proliferation by reducing the transforming growth factor-β (TGF-β) signalling, as the TGF-β induced the epithelial-mesenchymal-transition (EMT) in cancer cells [86]. Here, TGFB1 is linked to cancer.